StonvexLoading…
StonvexCore line items from TTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-30 | Annual 2025 2025-10-31 | Q3 2025 2025-08-01 | Q2 2025 2025-05-02 |
|---|---|---|---|---|
Revenue | $1.04B | $4.51B | $3.44B | $2.31B |
Operating Income | $87.10M | $409.90M | $317.40M | $252.60M |
Net Income | $67.90M | $316.10M | $243.10M | $189.60M |
EPS (Diluted) | $0.69 | $3.17 | $2.42 | $1.88 |
Total Assets | $3.70B | $3.44B | $3.52B | $3.79B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $189.00M | $341.00M | $201.00M | $176.50M |
Free Cash Flow OCF − CapEx | $14.60M | $578.30M | $291.90M | $84.70M |
Shares Outstanding | 96.93M | 97.89M | 97.85M | 99.01M |